Drug intelligence / Profile preview

Pranvit D3 Nano Shot (cholecalciferol)

Development stage: Unknown
Lead developer: Pranada Biopharma
Modality: Small Molecules
Administration: Oral

Overview

Pranvit D3 Nano Shot is an oral liquid formulation of cholecalciferol (vitamin D3) developed by Pranada Biopharma. It is designed as a nano-emulsion (nano shot) to enhance the absorption and bioavailability of vitamin D3. Cholecalciferol is a fat-soluble vitamin that plays a crucial role in regulating calcium and phosphorus homeostasis, which is essential for maintaining bone density, supporting immune function, and regulating insulin levels. Pranvit D3 Nano Shot is primarily indicated for the treatment and prevention of vitamin D deficiency, osteoporosis, and related bone disorders.

Brand names: Pranvit D3 Nano ShotPranvit D3 Nano Shots
Other names: colecalciferolvitamin D3

Targets

RXRA (Retinoid X receptor alpha)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Pranvit D3 Nano Shot (cholecalciferol).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pranvit D3 Nano Shot (cholecalciferol).